Apolipoprotein E and Alzheimer's disease: signal transduction mechanisms.
The three common apolipoprotein E (ApoE) alleles differentially contribute to the risk of Alzheimer's disease (AD). While the APOE genotype alters susceptibility to disease expression, individuals with APOE epsilon 4 alleles have the highest risk of developing AD; the APOE epsilon 4 allele is neither essential nor sufficient on its own to cause AD. Since the discovery, in 1992, of the involvement of APOE in AD, many scientists have explored the role of the ApoE isoforms in the central nervous system in an effort to elucidate their roles in the pathophysiological mechanism of this disease. While many hypotheses have been proposed, none has been proven. ApoE was discovered through investigations into cholesterol metabolism. In serum and in cerebrospinal fluid ApoE binds lipoprotein particles, which contain cholesterol esters, and is critical in the shuttling of cholesterol from cell to cell. Trafficking of ApoE is mediated by specific interactions with cell-surface receptors. As described later, several families of ApoE receptors with diverse functions have been discovered. The roles of these receptors are proving increasingly complex since additional interactions with other ligands and with other intracellular proteins are rapidly being identified. It was once thought that these receptors only shuttle ApoE-containing phospholipid particles from the extracellular environment into the cell, but they also transduce a number of additional intracellular signals and interactions. Molecular signalling cascades initiated by the various ApoE receptors modulate a number of critical cellular processes. To date, two functional classes of ApoE receptors have been identified. The first is the low-density lipoprotein receptor family and the second the scavenger receptor families.
Strittmatter
W J
WJ
Division of Neurology, Duke University Medical Center, Durham, NC 27710, USA.
D048868:Adaptor Proteins, Signal Transducing; D000483:Alleles; D000544:Alzheimer Disease / Q000235:genetics / Q000503:physiopathology*; D001057:Apolipoproteins E / Q000235:genetics / Q000502:physiology*; D018955:CD36 Antigens / Q000502:physiology; D020013:Calcium Signaling; D004705:Endocytosis; D006801:Humans; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins / Q000502:physiology; D009687:Nuclear Proteins / Q000502:physiology; D011971:Receptors, Immunologic; D011973:Receptors, LDL / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B; D015398:Signal Transduction
C091042:APBB1 protein, human; D048868:Adaptor Proteins, Signal Transducing; C486243:Apbb1 protein, mouse; D001057:Apolipoproteins E; D018955:CD36 Antigens; C115785:DAB1 protein, human; D026503:Low Density Lipoprotein Receptor-Related Protein-1; D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D011971:Receptors, Immunologic; D011973:Receptors, LDL; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B